1,891.70
-0.59%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Narayana Hrudayalaya
Its shares trade on NSE under the ticker NH.NS. It has been listed since 6 January 2016. In the fiscal year to 31 March 2026, it reported revenue of ₹78.96bn and net income of ₹8.06bn. At that date it held total assets of ₹124.74bn and shareholders' equity of ₹45.37bn.
Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-01-06. The firm is primarily engaged in the business of rendering medical and healthcare services. The company has a network of multispecialty and super specialty hospitals spread across multiple locations. The firm owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The firm has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 6 Jan 2016
- Employees
- 11,726
- Website
- narayanahealth.org ↗
Leadership
Pay as last reported
- Dr. Devi ShettyExecutive Chairman of the Board, Whole Time Director₹174.7m
- Dr. Emmanuel RupertGroup Chief Executive Officer, Managing Director, Executive Director, since 2019₹78.9m
- Mr. Viren ShettyExecutive Vice Chairman of the Board, since 2022₹34.6m
- Ms. Sandhya JayaramanGroup Chief Financial Officer₹27.2m
- Mr. Sridhar SeshiahGroup Company Secretary, Legal and Compliance Officer₹10.3m
- Dr. Kiran Mazumdar ShawNon-Executive Director₹3.3m
- Dr. Anesh ShettyNon-Executive Director₹250,000
- Mr. Shankar ArunachalamNon-Executive Independent Director₹3.5m
- Ms. Terri BresenhamNon-Executive Independent Director₹3.4m
- Dr. Nachiket MorNon-Executive Independent Director₹3.5m
- Ms. Nivruti RaiNon-Executive Independent Director₹250,000
- Mr. Naveen TewariNon-Executive Independent Director₹3.4m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 80
- Environment
- 87
- Social
- 74
- Governance
- 80
- Direct emissions (scope 1)
- 16,367.16 t
- Energy emissions (scope 2)
- 31,587.51 t
- Women in the workforce
- 59%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Narayana Hrudayalaya Ltd employs 11,726 full-time employees in Bangalore, India.
- The company operates 19 hospitals and three heart centers across India with over 5,860 operational beds.
- Narayana Hrudayalaya offers specialized medical services including heart transplant and stem cell transplant.
Weaknesses
- The company has a limited overseas presence with only Cayman Islands as an international location.
- Narayana Hrudayalaya's network is concentrated in India with no mention of expansion into other countries.
- The firm's business is solely focused on medical and healthcare services without diversification.
Opportunities
- Expanding the hospital network into new regions within India could increase market share.
- The growing demand for specialized medical services like heart transplants presents a significant opportunity.
- Narayana Hrudayalaya can leverage its 19 hospitals to enhance international partnerships.
Threats
- The healthcare sector faces increasing regulatory pressures in India and globally.
- Competition from other healthcare providers in Bangalore and across India poses a threat.
- Economic downturns may reduce patient numbers seeking non-essential medical services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.